ANDREA GUTIERREZ DE VELASCO: Open Payments
NPI 1306489745 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$303 in 10 payments from 8 companies in 2025. Trend: 2023 $502 · 2024 $238 · 2025 $303
Food & beverage: $303
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 1 | $108 |
| Dexcom, Inc. | 2 | $47 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| Aimmune Therapeutics, Inc. | 1 | $29 |
| Novo Nordisk Inc | 1 | $26 |
| ConvaTec Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
Products named: Barostim Neo System, Dexcom G6 Transmitter, VOWST, AQUACEL AG+ EXTRA, JARDIANCE, CAPVAXIVE, GARDASIL 9, GEMTESA.
Industry payments across TX — which companies pay providers there.
